118 related articles for article (PubMed ID: 3278186)
1. Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutions.
Kashima H; Leventhal B; Clark K; Cohen S; Dedo H; Donovan D; Fearon B; Gardiner L; Goepfert H; Lusk R
Laryngoscope; 1988 Mar; 98(3):334-40. PubMed ID: 3278186
[TBL] [Abstract][Full Text] [Related]
2. Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis.
Leventhal BG; Kashima HK; Weck PW; Mounts P; Whisnant JK; Clark KL; Cohen S; Dedo HH; Donovan DJ; Fearon BW
Arch Otolaryngol Head Neck Surg; 1988 Oct; 114(10):1163-9. PubMed ID: 3046638
[TBL] [Abstract][Full Text] [Related]
3. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group.
Leventhal BG; Kashima HK; Mounts P; Thurmond L; Chapman S; Buckley S; Wold D
N Engl J Med; 1991 Aug; 325(9):613-7. PubMed ID: 1861694
[TBL] [Abstract][Full Text] [Related]
4. Alpha-interferon (Wellferon) as an adjunct to standard surgical therapy in the management of recurrent respiratory papillomatosis.
Benjamin BN; Gatenby PA; Kitchen R; Harrison H; Cameron K; Basten A
Ann Otol Rhinol Laryngol; 1988; 97(4 Pt 1):376-80. PubMed ID: 3408112
[TBL] [Abstract][Full Text] [Related]
5. [The combined treatment of juvenile outset recurrent respiratory papillomatosis].
Xie J; Dong P; Li K; Wang J; Jin B; Zhang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Nov; 20(21):975-7. PubMed ID: 17219994
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial.
Healy GB; Gelber RD; Trowbridge AL; Grundfast KM; Ruben RJ; Price KN
N Engl J Med; 1988 Aug; 319(7):401-7. PubMed ID: 3398891
[TBL] [Abstract][Full Text] [Related]
7. Combined CO2-laser and alfa recombinant interferon treatment in five children with juvenile laryngeal papillomatosis.
Mattot M; Ninane J; Hamoir M; Moulin D; Mustin V; Vermylen C; Cornu G
Acta Clin Belg; 1990; 45(3):158-63. PubMed ID: 2166413
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of laryngotracheal papillomatosis with combined use of laser surgery and intralesional administration of alpha-interferon (Roferon)].
Walther EK; Herberhold C
Laryngorhinootologie; 1993 Oct; 72(10):485-91. PubMed ID: 8267824
[TBL] [Abstract][Full Text] [Related]
9. [The interferon status and circulating immunoglobulins during the interferon therapy of respiratory papillomatosis in children].
Pritsker AD; Grigorian SS; Onufrieva SS; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):411-4. PubMed ID: 1725077
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon-alpha-2C in laryngeal papillomatosis: preliminary results of a prospective multicentre trial.
Zenner HP; Kley W; Clarós P; Clarós A; Labas Z; Löbe LP; Pavelka R; Plath P; Ribari O; Niethammer D
Oncology; 1985; 42 Suppl 1():15-8. PubMed ID: 3909032
[TBL] [Abstract][Full Text] [Related]
11. [The effect of exogenous interferon on the in vitro production of alpha- and gamma-interferon by the lymphocytes of patients with respiratory papillomatosis].
Grigorian SS; Pritsker AD; Onufrieva EK; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):407-9. PubMed ID: 1803775
[TBL] [Abstract][Full Text] [Related]
12. [Results of long-term leukocyte interferon (alpha IFN) therapy using an individually determined dose schedule in recurrent laryngeal papillomatosis].
Gerein V; Lodemann E; Bell G; von Ilberg C; Kornhuber B
Klin Padiatr; 1987; 199(3):224-9. PubMed ID: 3114545
[TBL] [Abstract][Full Text] [Related]
13. [Effect of alpha-leukocyte interferon on laryngeal papillomatosis in children].
Vacher S; Peytral C; Narcy P
Presse Med; 1985 Jun; 14(24):1317-8. PubMed ID: 3161020
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of pulmonary metastasis from recurrent respiratory papillomatosis.
Silver RD; Rimell FL; Adams GL; Derkay CS; Hester R
Otolaryngol Head Neck Surg; 2003 Dec; 129(6):622-9. PubMed ID: 14663426
[TBL] [Abstract][Full Text] [Related]
15. 2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis.
Gerein V; Rastorguev E; Gerein J; Lodemann E; Pfister H; Draf W; Desloovere C
J Laryngol Otol; 2004 Oct; 118(10):750-6. PubMed ID: 15550179
[TBL] [Abstract][Full Text] [Related]
16. [Natural killer activity in respiratory papillomatosis and its changes after interferon treatment].
Pritsker AD; Grigorian SS; Onufrieva EK; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):409-11. PubMed ID: 1803776
[TBL] [Abstract][Full Text] [Related]
17. Palliative aspects of recurrent respiratory papillomatosis.
Johnson K; Derkay C
Otolaryngol Clin North Am; 2009 Feb; 42(1):57-70, viii. PubMed ID: 19134490
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent respiratory papillomatosis with interferon.
Sessions RB; Dichtel WJ; Goepfert H
Ear Nose Throat J; 1984 Oct; 63(10):488-93. PubMed ID: 6489206
[No Abstract] [Full Text] [Related]
19. Recurrent respiratory papillomatosis.
Kashima HK; Mounts P; Shah K
Obstet Gynecol Clin North Am; 1996 Sep; 23(3):699-706. PubMed ID: 8869953
[TBL] [Abstract][Full Text] [Related]
20. Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Programme (1994-1999 report).
Nodarse-Cuní H; Iznaga-Marín N; Viera-Alvarez D; Rodríguez-Gómez H; Fernández-Fernández H; Blanco-López Y; Viada-González C; López-Saura P;
J Laryngol Otol; 2004 Sep; 118(9):681-7. PubMed ID: 15517700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
